Literature DB >> 21875417

The effects of tadalafil on renal ischemia reperfusion injury: an experimental study.

Feyzul Gasanov1, Berna Aytac, Hakan Vuruskan.   

Abstract

Many pharmacological agents were investigated for the prevention of renal ischemic reperfusion (I/R) injury as well as the phosphodiesterase (PDE) inhibitors. The aim of the study was to examine the possible renoprotective effect of a member in this family, tadalafil (Td) on I/R injury. Thirty-six Spraque Dawley rats were allocated to six groups as; control, sham, ischemia (I), ischemia/reperfusion (I/R), Td pretreatment ischemia (Td/I) and Td pretreatment ischemia/reperfusion (Td/IR) groups. Right nephrectomy was performed in all groups. Td was dissolved in saline solution and given as a single dose (1mg/kg) through an orogastrictube 60 min before the operation in the Td pretreatment groups. In ischemia group the left renal pedicle was occluded for 45 minutes and after than underwent left nephrectomy. In I/R group left renal pedicle was occluded for 45 minutes, reperfused for 1hour and after then underwent nephrectomy. The left kidneys were evaluated after standard laboratory procedures with regard to tubular morphology, and leukocyte infiltration. The data were analyzed by using Kruskal-Wallis test to determine differences among the groups. A p value of < 0.05 was considered significant. Renal tubular damage was significant increased in the ischemia and I/R group (Groups III and IV) when compared to those in the sham group (Group II), (p = 0.004, 0.004, respectively). Tubular damage, in the Td pretreatment ischemia (Td/I) (Group V) and Td pretreatment ischemia/reperfusion (Td/IR) (Group VI) were less than that in the ischemia group (Group III) (p= 0.010, p= 0.025, respectively). Td administration prior to the renal I/R injury attenuated these morphological disarrangements, which were observed in renal I/R. Tubular necrosis, which may be considered as an important issue of the developing renal injury, was also completely prevented with Td administration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875417      PMCID: PMC4362549          DOI: 10.17305/bjbms.2011.2567

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  33 in total

Review 1.  Guanylyl cyclases and signaling by cyclic GMP.

Authors:  K A Lucas; G M Pitari; S Kazerounian; I Ruiz-Stewart; J Park; S Schulz; K P Chepenik; S A Waldman
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

2.  Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.

Authors:  John Wharton; Julian W Strange; Gigi M O Møller; Ellena J Growcott; Xiaohui Ren; Angela P Franklyn; Stephen C Phillips; Martin R Wilkins
Journal:  Am J Respir Crit Care Med       Date:  2005-04-07       Impact factor: 21.405

3.  Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP.

Authors:  Akio Mizutani; Kazunori Murakami; Kenji Okajima; Shin-Ichiro Kira; Sachiko Mizutani; Kyosuke Kudo; Junji Takatani; Koji Goto; Seiji Hattori; Takayuki Noguchi
Journal:  Shock       Date:  2005-09       Impact factor: 3.454

4.  The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size.

Authors:  C Sesti; V Florio; E G Johnson; R A Kloner
Journal:  Int J Impot Res       Date:  2006-07-20       Impact factor: 2.896

5.  Effects of olprinone, a phosphodiesterase III inhibitor, on ischemic acute renal failure.

Authors:  Chabouk Anas; Takenori Ozaki; Shoichi Maruyama; Tokunori Yamamoto; Momoka Zu Gotoh; Yoshinari Ono; Seiichi Matsuo
Journal:  Int J Urol       Date:  2007-03       Impact factor: 3.369

6.  Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.

Authors:  M D Okusa; J Linden; L Huang; D L Rosin; D F Smith; G Sullivan
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

7.  Sildenafil attenuates renal ischemia reperfusion injury by decreasing leukocyte infiltration.

Authors:  Ozgur Oruc; Kubilay Inci; Fazil Tuncay Aki; Dilara Zeybek; Sevda F Muftuoglu; Kamer Kilinc; Ali Ergen
Journal:  Acta Histochem       Date:  2009-03-25       Impact factor: 2.479

8.  Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits.

Authors:  Ramzi Ockaili; Fadi Salloum; John Hawkins; Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09       Impact factor: 4.733

Review 9.  The role of neutrophils in acute renal failure.

Authors:  S Lauriat; S L Linas
Journal:  Semin Nephrol       Date:  1998-09       Impact factor: 5.299

10.  Apart from the other members of PDE inhibitors' family, enoximone does not enhance renal ischemic reperfusion injury: the effects of enoximone on renal ischemia reperfusion.

Authors:  Arzu Pampal; I Onur Ozen; Billur Demirogullari; I Hakki Gol; M Meral Guclu; Neslihan Bukan; Aylar Poyraz; Ramazan Karabulut; A Can Basaklar; Nuri Kale
Journal:  Ren Fail       Date:  2009       Impact factor: 2.606

View more
  6 in total

1.  7,8-dihydroxycoumarin has a dual mechanism of action in hepatic ischemia reperfusion injury.

Authors:  Hai-Yang Zhu; Hong-Wei Gao; Shu-Feng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection?

Authors:  Iason Kyriazis; George C Kagadis; Panagiotis Kallidonis; Ioannis Georgiopoulos; Antonia Marazioti; Aikaterini Geronasiou; Despοina Liourdi; George Loudos; Vasilios Schinas; Dimitris Apostolopoulos; Helen Papadaki; Christodoulos Flordellis; George C Nikiforidis; Andreas Papapetropoulos; Evangelos Nu Liatsikos
Journal:  World J Urol       Date:  2012-11-10       Impact factor: 4.226

3.  The protective effect of diosmin on hepatic ischemia reperfusion injury: an experimental study.

Authors:  Yusuf Tanrikulu; Mefaret Sahin; Kemal Kismet; Sibel Serin Kilicoglu; Erdinc Devrim; Ceren Sen Tanrikulu; Esra Erdemli; Serap Erel; Kenan Bayraktar; Mehmet Ali Akkus
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

4.  The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model.

Authors:  Yusuf Özlülerden; Cihan Toktaş; Hülya Aybek; Vural Küçükatay; Nilay Şen Türk; Ali Ersin Zumrutbas
Journal:  Investig Clin Urol       Date:  2017-06-27

5.  The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study.

Authors:  Kerem Özbek; Köksal Ceyhan; Fatih Koç; Erkan Söğüt; Fatih Altunkaş; Metin Karayakalı; Ataç Çelik; Hasan Kadı; R Doğan Köseoğlu; Orhan Önalan
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

Review 6.  Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review.

Authors:  Georgios Georgiadis; Ioannis-Erineos Zisis; Anca Oana Docea; Konstantinos Tsarouhas; Irene Fragkiadoulaki; Charalampos Mavridis; Markos Karavitakis; Stavros Stratakis; Kostas Stylianou; Christina Tsitsimpikou; Daniela Calina; Nikolaos Sofikitis; Aristidis Tsatsakis; Charalampos Mamoulakis
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.